Go Back   ITalkCash.com - Forum for financial investments > Public Investment > Penny Stocks
Forum Register Calendar Search Today's Posts Mark Forums Read

Vivk news - penny stocks

Reply
 
LinkBack Thread Tools Display Modes
Old 06-04-2010, 06:53 PM
ItalkCash User
 
Join Date: Oct 2009
Posts: 127
Default Vivk news

I just got alerted on VIVK. VIVK is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. Comapny came with news this morning and looks like its setting itself up for a strong run next week. Awesome time to take a position in this one. Here is the latest news

Vivakor Announces Substantial Reduction of Company's Long Term Debt Position and Finalizes Health America Inc. Acquisition

CORALVILLE, Iowa, Jun 4, 2010 (GlobeNewswire via COMTEX) -- Vivakor, Inc. (OTCBB:VIVK) today announced the Company has reduced its long and short term debt by an additional $510,000 by converting those debts to shares of common stock. This substantial debt reduction through conversion to stock finalizes the acquisition payments for Health America Inc. and the VIVASLICES MRI software technology, which the company purchased in August of 2008. VIVASLICES is a software technology which increases image resolution of previous generations of MRI units, thereby saving hospitals and clinics with older equipment millions of dollars in costs related to purchasing new MRI units with enhanced image resolution capacity.

Vivakor Executive Chairman Matt Nicosia added this statement to the news: "This reduction of the Company's debt represents both the positive outlook by management and its creditors as we make progress on both the commercialization of VIVASLICES and other Vivakor technologies. Additionally the Company has now eliminated all of its long term debt, which increases shareholder equity and improves the balance sheet. This elimination of long term debt allows the Company to devote its resources to technology commercialization and development. We look forward to completing the Company's financing needs which will add to the Company's sustainability and improve the outlook for Vivakor."
Reply With Quote
Old 06-07-2010, 03:24 PM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default VIVK Vivakor Inc

VIVK_K
+5.69% With A Days Range of 0.0369 X .05
The MA20 @ 0.047 / MA50 @ 0.072
IMO cuold see VIVK_K test or possible push thru
Resistance @ .05 This Week
Record breaking volume 18 X The Daily Avg
RSI @ 41.90
MAC D pulled away from the signal
Hister Gram showing Positive Diversion
ULT In The Buyers Range @ 45.47
News After the Close Friday
Vivakor Announces Receipt of LOI for $600k Investment
Vivakor Announces Receipt of LOI for $600k Investment - Yahoo! Finance
Vivakor, Inc. (OTC:VIVK) New "Featured Report"
OTCReporter.com :: VIVAKOR, INC Trading Alerts
Click here to Watch a Video Chart of VIVK(+8.4%)
TechSmith | Screencast.com, online video sharing, VIVK for June 7th 2010
For more information Visit their Web Site
Vivakor - Overview
Keep your in Portfolio
Reply With Quote
Old 06-08-2010, 02:24 AM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default Vivk

.Vivakor Extends Its Business Development Agreement With Baker Consulting

Buzz up! 0 Print..Companies:Vivakor, Inc..Related Quotes
Symbol Price Change
VIVK.OB 0.03 -0.01


{"s" : "vivk.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Vivakor, Inc. On Monday June 7, 2010, 6:14 pm EDT

CORALVILLE, Iowa, June 7, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) has extended its Business Development agreement with Baker Consulting out of Walnut Creek, California and its affiliate group, Kyouko Group, Inc. out of South Florida for an additional six months. Baker Consulting has made great strides in assisting the company with distribution agreements and research collaboration. Vivakor's Chairman Matt Nicosia stated recently, "Baker Consulting, with its vast experience in medical device commercialization and corporate finance, has been very instrumental in our Company's commercialization efforts and we are very pleased in the progress that has been made thus far and we look forward to creating great value for Vivakor shareholders through this relationship."



About Vivakor, Inc.



Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handing and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at Vivakor - Overview.
Reply With Quote
Old 06-09-2010, 12:08 AM
ItalkCash User
 
Join Date: Oct 2009
Posts: 524
Default Vivk

.Vivakor Expands Market for VivaSight Technologies to Adult Vision Care and Further Increases Revenue Outlook

Buzz up! 0 Print..Companies:Vivakor, Inc..Related Quotes
Symbol Price Change
VIVK.OB 0.0235 -0.0065


{"s" : "vivk.ob","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00", "o" : "","j" : ""} Press Release Source: Vivakor, Inc. On Tuesday June 8, 2010, 7:46 pm

CORALVILLE, Iowa, June 8, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK - News) announced new markets for its VivaSight technologies and further increased revenue projections for its VivaSight division. The new market mainly includes adult vision care to be used by Ophthalmologists and Optometrists. Speaking about this new development, Matt Nicosia, Vivakor's Chairman, said, "Adult vision care is a growing market with an aging population. Existing vision screening devices do not properly detect adult issues and our technology has the capability of addressing this need. VivaSight technology is useful mainly for children's screening but has the potential to be a very valuable asset in adult vision care. Our devices use cutting edge technology developed by our multidisciplinary research model to save time and money while enhancing exactness in all our detection efforts."



Additionally, VivaSight technologies will be marketed as the best and most versatile vision screening devices on the market. Mr. Matt Nicosia stated, "The market for vision screening is not just limited to United States vision care. We have received significant attention through our commercialization partners for international use of the VivaSight technology for both private practice and government mandated vision care." This announcement will expand upon Vivakor's recently released revenue projections for its VivaSight division and increase the estimated market to $50 million annually.



About Vivakor, Inc.



Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at Vivakor - Overview.
Reply With Quote
Reply

Thread Tools
Display Modes


Lotto Premium Bonds Book hotel room.



Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2012, vBulletin Solutions, Inc.
Search Engine Friendly URLs by vBSEO 3.6.0